More than three-quarters of the state’s 13,000 or so medical marijuana-eligible patients have purchased the drug, but only half of the 13,000 are repeat buyers under the tightly regulated state program, according to Department of Health data provided to the Times Union.
Through late January, 12,933 patients had been certified by their doctors to participate in the state’s medical marijuana program and 10,250 patients had been dispensed a medical marijuana product. But the number of patients who had been dispensed a product more than once was 6,403.
That data backs up anecdotal evidence about patients’ purchasing habits over the first year of the program. While the five companies authorized to sell medical marijuana products have had products to offer, demand has been on a slower growth curve than the businesses would like.
These less-than-robust sales have caused issues for patients, including prohibitive prices they must cover out of pocket because insurance does not cover medical marijuana.
Diagnosing why about half of all patients aren’t returning to pick up a second round of medicine isn’t an exact science. [Read more at Times Union]
Source: Cannabis Business Executive